First needle less COVID vaccines for children and adult above 12 years got approval for EUA

Zydus Cadila’s ZyCov-D, Covid vaccine got Emergency Use Authorization for children and adults 12 years and above

The drug regulator of India approved Zydus Cadila’s three-dose COVID19 DNA vaccine for emergency use authorization for children 12 years and above. This is the second homegrown vaccine that has got approval against the deadly COVID19 infection. 

The company has applied for authorization of ZyCov-D on July 1st. It has an efficacy rate of 66.66 % in a late-stage trial of more than 28,000 volunteers nationwide. The company has developed vaccines in partnership with the Department of Biotechnology. ZyCoV-D is the world's first plasmid DNA vaccine against coronavirus. The company has planned to manufacture 100-120 million doses annually.

All about ZyCov-D

ZyCov-D is a three-dose vaccine when injected produces the spike protein of the SARS-CoV-2 virus. ZyCov-D is effective against mutant strains of virus-like delta variants which are highly infectious. It will be administered on the 1st day – 28th day – 56th day. It elicits an immune response, which plays a vital role in protection from the disease as well as viral clearance. It is an intradermal vaccine, applied using a ‘needle-free injector’. A needle-free system can lead to a significant reduction in side effects. The vaccine has been developed in partnership with the department under Mission COVID Suraksha.

It is the world's first and India's indigenously developed DNA-based vaccine for COVID-19 to be administered in humans including children and adults 12 years and above. Bharat Biotech’s Covaxin and ZydusCadila’s ZyCov-D are the only two vaccine candidates to have been tested among children in India and developed in India. 

Tags : #Spotlight #ZyCov-D #Covaxin #COVIDVaccine #Firstcovidvaccineforchildren12yearsandabove #NeedlelessCOVIDVaccine #ZydusCadila #Medicircle #SmitaKumar

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Healthcare Startups to Watch Out for in 2025December 20, 2024
Biobank Blueprint: Redefining Diabetes Diagnosis and Treatment in IndiaDecember 20, 2024
The Future of Malaria Prevention: Can This Vaccine Eliminate the Disease?December 20, 2024
Why the World Trusts Indian Pharmaceuticals for Life-Saving SolutionsDecember 20, 2024
International Tsunami Conference Concludes at AmritapuriDecember 20, 2024
Prestige Marks 75 Years of Revolutionizing Home Cooking with Iconic Innovative ProductsDecember 20, 2024
Revolutionizing Education: Online Learning Platforms Transforming Study Materials for Board and Competitive ExamsDecember 19, 2024
Why Your Blood Pressure Reading Might Be a Lie and How to Fix ItDecember 19, 2024
Vaccines, Cards, and Digital Records: How India is Fighting Healthcare InequalityDecember 19, 2024
Bridging Borders: Sri Lanka’s President Explores India’s Healthcare and HeritageDecember 19, 2024
Jeevan Jyoti Project Brings Eye Care to Alwar's Rural CommunitiesDecember 19, 2024
Crompton Launches New Range of Decorative Wall Lights Providing a Perfect Blend of Uniqueness & AestheticsDecember 19, 2024
Can One Injection End Decades of HIV Inequality?December 19, 2024
Multi-Organ Marvel: How a 12-Hour Surgery Gave a Businessman New LifeDecember 19, 2024
Jupiter Hospital Celebrates BMT Heroes: Honoring Patients, Donors, and Advancing Care with New MilestonesDecember 18, 2024
Beware of Fraudulent Activities in the Name of Asian HospitalDecember 17, 2024
Why Feeling Lonely Can Be as Dangerous as Smoking for Your BrainDecember 17, 2024
Rethinking Intelligence: How Brain Connectivity Defines Our Intellectual PotentialDecember 17, 2024
Lonely in a Crowd: When Socializing Fails to Heal Young MindsDecember 17, 2024
How many hours of sleep are children getting on average now compared to before the pandemic?December 17, 2024